(S (NP-SBJ-62 (NP (NN Chromosome) (CD 1) (NN aneusomy)) (PP (IN with) (NP (NN 1p36) (NN under-representation)))) (VP (VBZ is) (ADJP-PRD (JJ related) (PP (TO to) (NP (NP-COOD (NP (JJ histologic) (NN grade)) (, ,) (NP (NN DNA) (NN aneuploidy)) (, ,) (NP (JJ high) (NN c-erb) (NN B-2)) (CC and) (NP (NP (NN loss)) (PP (IN of) (NP (NN bcl-2) (NN expression))))) (PP (IN in) (NP (JJ ductal) (NN breast) (NN carcinoma))))))) (. .))
(S (NP-SBJ-63 (NP (NN Chromosome) (CD 1) (NNS abnormalities)) (PP (IN with) (NP (NP (NN loss)) (PP (IN of) (NP (NN 1p36)))))) (VP (VBP have) (VP (VBN been) (VP (VBN investigated) (NP (-NONE- *-63)) (PP (IN in) (NP (CD 95) (NN breast-cancer) (NNS samples))) (PP (IN by) (NNS means) (IN of) (NP (NP (DT a) (JJ dual-target) (NP (NP (NN fluorescence) (FW in-situ) (NN hybridization)) (PRN (-LRB- -LRB-) (NP (NN FISH)) (-RRB- -RRB-))) (NN technique)) (VP (VBG using) (NP (NP (DT the) (NP-COOD (NP (NN pUC) (CD 1.77)) (CC and) (NP (NN p1-79))) (NNS probes)) (, ,) (ADJP (JJ specific) (PP (IN for) (NP (DT the) (NP-COOD (NP (NN 1q12)) (CC and) (NP (NN 1p36))) (NNS regions))) (, ,) (ADVP (RB respectively)))))))))) (. .))
(S (NP-SBJ-64 (NP (NNS Abnormalities)) (PP (IN for) (NP-COOD (NP (CD one)) (CC or) (NP (DT both) (NNS probes))))) (VP (VBD were) (VP (VBN detected) (NP (-NONE- *-64)) (PP (IN in) (NP (CD (95 83)) (NNS samples))))) (. .))
(S (NP-SBJ-65 (JJ Relative) (NN 1p36) (NN under-representation)) (VP (VBD was) (VP (VBN found) (NP (-NONE- *-65)) (PP (IN in) (NP (CD (95 79)))))) (. .))
(S (NP-SBJ-66 (NP (DT The) (JJ clinical) (NN relevance)) (PP (IN of) (NP (DT these) (NNS alterations)))) (VP (VBD was) (VP (VBN studied) (NP (-NONE- *-66)) (PP (IN by) (S (NP-SBJ (-NONE- *)) (VP (VBG comparing) (NP (DT the) (NN FISH) (NNS results)) (PP (IN with) (NP (NP (JJ several) (NNS parameters)) (VP (ADVP-TMP (RB currently)) (VBN used) (NP (-NONE- *)) (PP (IN in) (NP (JJ breast-cancer) (NN pathology))))))))))) (. .))
(S (NP-SBJ-67 (NP (JJ Distinct) (NNS patterns)) (PP (IN of) (NP (NN chromosome) (CD 1) (NNS abnormalities)))) (VP (VBD were) (VP (VBN found) (NP (-NONE- *-67)) (PP (IN among) (NP (NP (DT the) (JJ histologic) (NNS types)) (PP (IN of) (NP (NN breast) (NN carcinoma))))))) (. .))
(S-COOD (S (NP-SBJ (ADJP-COOD (ADJP (JJ Lobular)) (CC or) (ADJP (JJ mucinous))) (NNS samples)) (VP (VBD showed) (NP (QP (JJ few) (CC or) (DT no)) (NNS alterations)))) (, ,) (IN whereas) (S (NP-SBJ (JJS most) (JJ ductal) (NNS samples)) (VP (VBD had) (NP (NP (JJ high) (NN chromosome) (CD 1) (NN polysomy)) (PP (IN with) (NP (NP (NN under-representation)) (PP (IN of) (NP (NN 1p36)))))))) (. .))
(S (PP (IN In) (NP (JJ ductal) (NNS carcinomas))) (, ,) (NP-SBJ (NN chromosome) (CD 1) (NNS alterations)) (VP (VBD increased) (PP (IN with) (NP-COOD (NP (JJ histologic) (NN grade)) (, ,) (NP (NN DNA) (NN aneuploidy)) (, ,) (NP (NP (NN loss)) (PP (IN of) (NP (NN bcl-2)))) (CC and) (NP (JJ high) (NN c-erb) (NN B-2) (NN expression))))) (. .))
(S (NP-SBJ-68 (DT These) (NNS associations)) (VP (VBD were) (VP (VBN found) (S (NP-SBJ (-NONE- *-68)) (VP (TO to) (VP (VB be) (ADVP (RB statistically)) (ADJP-PRD (JJ significant))))))) (. .))
(S (NP-SBJ-69 (NP (DT No) (NN correlation)) (PP (IN between) (NP-COOD (NP (NN chromosome) (CD 1) (NNS alterations)) (CC and) (NP-COOD (NP (JJ nuclear) (NP-COOD (NP (NN grade)) (, ,) (NP (NN age)) (, ,) (NP (NN size)))) (, ,) (NP (JJ lymph-node) (NN involvement)) (, ,) (NP (JJ hormonal) (NN receptor) (NN presence)) (, ,) (NP (NN proliferation) (NN activity)) (CC or) (NP (NN p53) (NN protein) (NN expression)))))) (VP (VBD was) (VP (VBN detected) (NP (-NONE- *-69)))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP (VBP indicate) (NP (NP (DT the) (NN utility)) (PP (IN of) (NP (DT this) (NN FISH) (NN technique))) (PP (IN for) (NP (NP (DT a) (JJR better) (NN definition)) (PP (IN of) (NP (NP (DT the) (JJ biological) (NNS characteristics)) (PP (IN of) (NP (JJ ductal) (NNS carcinomas))))))))) (. .))
